ArticleJournal of controlled release : official journal of the Controlled Release Society2019

Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain.

Oscar A Marcos-Contreras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.